• 17th May 2017

On the 8th May 2017, the clinical cancer genetics leads across the UK met to agree the set of genes with good evidence for being associated with breast, ovarian, colorectal cancer and polyposis syndromes.

An agreement was reached about which genes clinicians would approve being testing for in clinical diagnostic labs.



 This meeting will be followed up by:

- Compilation of a gene dossier for UKGTN for breast, ovarian and colorectal cancer/polyposis panel testing

- CGG-produced pragmatic management suggestions for all genes included to facilitate consistency across the UK, whilst acknowledging local constraints and protocols